Mice lacking beta-adrenergic receptors have increased bone mass but are not protected from deleterious skeletal effects of ovariectomy.
Activation of beta2-adrenergic receptors inhibits osteoblastic bone formation and enhances osteoclastic bone resorption. Whether beta-blockers inhibit ovariectomy-induced bone loss and decrease fracture risk remains controversial. To further explore the role of beta-adrenergic signaling in skeletal acquisition and response to estrogen deficiency, we evaluated mice lacking the three known beta-adrenergic receptors (beta-less). Body weight, percent fat, and bone mineral density were significantly higher in male beta-less than wild-type (WT) mice, more so with increasing age. Consistent with their greater fat mass, serum leptin was significantly higher in beta-less than WT mice. Mid-femoral cross-sectional area and cortical thickness were significantly higher in adult beta-less than WT mice, as were femoral biomechanical properties (+28 to +49%, P < 0.01). Young male beta-less had higher vertebral (1.3-fold) and distal femoral (3.5-fold) trabecular bone volume than WT (P < 0.001 for both) and lower osteoclast surface. With aging, these differences lessened, with histological evidence of increased osteoclast surface and decreased bone formation rate at the distal femur in beta-less vs. WT mice. Serum tartrate-resistance alkaline phosphatase-5B was elevated in beta-less compared with WT mice from 8-16 wk of age (P < 0.01). Ovariectomy inhibited bone mass gain and decreased trabecular bone volume/total volume similarly in beta-less and WT mice. Altogether, these data indicate that absence of beta-adrenergic signaling results in obesity and increased cortical bone mass in males but does not prevent deleterious effects of estrogen deficiency on trabecular bone microarchitecture. Our findings also suggest direct positive effects of weight and/or leptin on bone turnover and cortical bone structure, independent of adrenergic signaling.
Bouxsein
M L
ML
Orthopedic Biomechanics Laboratory, Beth Israel Deaconess Medical Center, 330 Brookline Avenue, Boston, Massachusetts 02215, USA. mbouxsei@bidmc.harvard.edu
Devlin
M J
MJ
Glatt
V
V
Dhillon
H
H
Pierroz
D D
DD
Ferrari
S L
SL
D000375:Aging / Q000502:physiology; D000818:Animals; D001696:Biomechanical Phenomena; D001823:Body Composition / Q000502:physiology; D015519:Bone Density / Q000235:genetics*; D005260:Female; D005269:Femur / Q000033:anatomy & histology / Q000000981:diagnostic imaging / Q000502:physiology; D008159:Lumbar Vertebrae / Q000000981:diagnostic imaging; D008297:Male; D051379:Mice; D018345:Mice, Knockout; D010052:Ovariectomy / Q000009:adverse effects*; D011943:Receptors, Adrenergic, beta / Q000172:deficiency*; D013131:Spine / Q000033:anatomy & histology / Q000502:physiology; D014057:Tomography, X-Ray Computed
D011943:Receptors, Adrenergic, beta
Bone. 2008 May;42(5):837-40
18295563
Osteoporos Int. 2007 Sep;18(9):1189-95
17333446
J Clin Densitom. 2003 Spring;6(1):25-33
12665699
Cell Tissue Res. 1991 Jun;264(3):469-80
1714353
J Bone Miner Res. 2001 Sep;16(9):1682-7
11547838
Endocrinology. 2005 Apr;146(4):1854-62
15705780
J Am Geriatr Soc. 2005 Mar;53(3):550-2
15743312
Bone. 2005 Nov;37(5):622-33
16157516
Obes Res. 2000 Aug;8(5):392-8
10968731
Cell. 2002 Nov 1;111(3):305-17
12419242
JAMA. 2004 Sep 15;292(11):1326-32
15367554
Endocrinology. 2005 Jan;146(1):503-10
15498888
Neuroscience. 2005;134(3):947-63
15994021
J Musculoskelet Neuronal Interact. 2008 Apr-Jun;8(2):94-104
18622078
J Musculoskelet Neuronal Interact. 2008 Apr-Jun;8(2):105-10
18622079
J Bone Miner Res. 2005 Apr;20(4):613-8
15765180
Bone. 1993 Jul-Aug;14(4):595-608
8274302
Mamm Genome. 2003 Feb;14(2):97-104
12584605
Science. 2002 Aug 2;297(5582):843-5
12161655
Bone Miner. 1993 Dec;23(3):301-15
7908582
Int J Obes Relat Metab Disord. 2001 Nov;25(11):1680-8
11753591
J Bone Miner Res. 1987 Dec;2(6):595-610
3455637
Bone. 2007 Aug;41(2):206-15
17543595
Obesity (Silver Spring). 2006 Aug;14(8):1312-9
16988073
Cell. 2000 Jan 21;100(2):197-207
10660043
Bone. 2006 Aug;39(2):260-7
16531131
Calcif Tissue Int. 2004 Nov;75(5):365-72
15592792
Recent Prog Horm Res. 2001;56:309-28
11237219
Bone. 2004 Nov;35(5):1046-58
15542029
Comput Methods Biomech Biomed Engin. 1997;1(1):15-23
11264794
J Bone Miner Res. 1999 Dec;14(12):2159-66
10620076
Life Sci. 1999;64(24):2299-306
10374920
J Biol Chem. 2006 Aug 18;281(33):23436-44
16785231
Bone. 2007 May;40(5):1209-16
17324648
J Biol Chem. 2005 Aug 26;280(34):30192-200
15961387
J Bone Miner Res. 2007 Apr;22(4):578-88
17243867
Bone. 1998 May;22(5):471-8
9600780
J Intern Med. 2006 Oct;260(4):350-62
16961672
Science. 1986 May 16;232(4752):868-71
3518059
J Bone Miner Res. 2005 Apr;20(4):635-43
15765183
J Biol Chem. 1995 Dec 8;270(49):29483-92
7493988
J Bone Miner Res. 2004 Jan;19(1):19-24
14753732
J Biol Chem. 1999 Jun 11;274(24):16701-8
10358009
J Pharmacol Exp Ther. 2006 Sep;318(3):1118-27
16740619
Nature. 2005 Mar 24;434(7032):514-20
15724149
J Clin Endocrinol Metab. 2005 Sep;90(9):5212-6
15998769
Osteoporos Int. 2008 Jul;19(7):905-12
17924050
Bone. 2005 Nov;37(5):688-98
16140599
Bone. 2004 Mar;34(3):376-83
15003785
Neurosci Lett. 1997 Sep 19;233(2-3):125-8
9350848
J Bone Miner Res. 2006 Oct;21(10):1591-9
16995814